We are pleased to communicate that the randomized clinical study RSKC001 has been granted by the Italian Ministry of Health according to new Medical Device Regulation (MDR) 2017/745.
The scope of the study is to validate the theranostic-guided corneal cross-linking for precise and personalized keratoconus management.
Follow us on www.regensight.com or contact us at clinicaltrials@regensight.com to know more about the study.
